Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial Journal Articles Refereed uri icon

Overview

Published in

  • The Lancet Haematology

Time

Date/time value

  • 2015

Identity

Digital Object Identifier (DOI)

  • 10.1016/S2352-3026(15)00115-5

Additional Document Info

Parent Title

  • LANCET HAEMATOLOGY

Volume

  • 2

Issue

  • 9

Publisher

  • The Lancet Publishing Group